Catch pre-market movers with AI signals.
TERN(Quitar la ciudad)
Terns (TERN) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Terns market cap is -- and enterprise value is --.
Share Statistics
Terns has 115.52M shares outstanding, with a free float of 104.94M.
Valuation Ratios
Terns's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
Terns debt-to-equity ratio is 0 and debt-to-assets ratio is 0.02.
Liquidity
Terns's current ratio is 62.41, quick ratio is 62.41, and cash ratio is 62.09, showing its short-term liquidity position.
Return on Capital
Terns's ROE is -14.23%, ROA is -13.85%, and ROIC is -16.37%, showing its return on capital profile.
Profitability
Terns gross margin is --, operating margin is --, and net margin is --.
Operating Efficiency
Terns's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
Terns's revenue is --, gross profit is --, net income is -96.21M, and EBITDA is -109.62M.
Balance Sheet
Terns's total debt is 0, net debt is 0, total equity is 1.01B, and cash is 1.02B.
Cash Flow Statement
Terns's operating cash flow is -82.18M, free cash flow is -82.18M, and CapEx is 0.
Dividends & Yields
Terns dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
Terns's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A clinical-stage biopharmaceutical company that develops small-molecule products for serious diseases, including oncology, obesity and NASH
Per Share Metrics
Terns's EPS is -1.03, book value per share is 8.96, and free cash flow per share is -0.73.
